Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2008; 14(47): 7175-7182
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7175
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7175
Table 5 Cell cycle of HepG2/Si-Mock and HepG2/Si-1 treated with or without GABA at a concentration of 40 μmol/L (mean ± SD)
HepG2/Si-Mock | HepG2/Si-Mock+GABA | HepG2/Si-1 | HepG2/Si-1+GABA | |
G1/G0% | 51.7 ± 3.53 | 49.3 ± 3.23 | 54.5 ± 3.37 | 59.4 ± 3.85 |
G2/M% | 15.7 ± 1.75 | 7.2 ± 0.92 | 17.6 ± 1.64 | 15.6 ± 1.69 |
S% | 32.4 ± 2.12 | 43.6 ± 2.841 | 27.6 ± 1.92 | 25.5 ± 2.06 |
- Citation: Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, Hu JY, Li GC. Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor α3 subunit. World J Gastroenterol 2008; 14(47): 7175-7182
- URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7175.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.7175